Cargando…
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at risk of exacerbations and pneumonia; how the risk factors interact is unclear. METHODS: This post-hoc, pooled analysis included studies of COPD patients treated with inhaled corticosteroid (ICS)/long-acting β(2) agonist (L...
Autores principales: | Hartley, Benjamin F., Barnes, Neil C., Lettis, Sally, Compton, Chris H., Papi, Alberto, Jones, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945447/ https://www.ncbi.nlm.nih.gov/pubmed/31907054 http://dx.doi.org/10.1186/s12931-019-1262-0 |
Ejemplares similares
-
Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease
por: Pascoe, Steven J., et al.
Publicado: (2019) -
A pooled analysis of the risk prediction models for mortality in acute exacerbation of chronic obstructive pulmonary disease
por: Ji, Zile, et al.
Publicado: (2023) -
Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease
por: Bornheimer, Rebecca, et al.
Publicado: (2017) -
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018) -
Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
por: Naya, Ian, et al.
Publicado: (2019)